What drugs does MATRIX LABS LTD make?

MATRIX LABS LTD has 14 FDA-approved drugs including LAMIVUDINE; ZIDOVUDINE.

What therapeutic areas does MATRIX LABS LTD focus on?

MATRIX LABS LTD focuses primarily on Immunology and Infectious Disease.

Data updated: Mar 10, 2026

MATRIX LABS LTD

ImmunologyInfectious Disease

Pharma

MATRIX LABS LTD is a pharmaceutical company focused on Immunology, Infectious Disease. Key products include LAMIVUDINE; ZIDOVUDINE.

Since

Drugs

Trials

Approved (2yr)

Key Drugs

LAMIVUDINE; ZIDOVUDINE

lamivudine

· 2015

Recent Activity

ATAZANAVIR SULFATE 2025-08-12

Labeling

ATAZANAVIR SULFATE 2025-08-12

Labeling

ATAZANAVIR SULFATE 2025-08-12

Labeling

ATAZANAVIR SULFATE 2025-07-23

Labeling

ATAZANAVIR SULFATE 2025-07-17

Labeling

ATAZANAVIR SULFATE 2025-06-26

Labeling

ATAZANAVIR SULFATE 2025-05-08

Labeling

AMLODIPINE AND OLMESARTAN MEDOXOMIL 2025-05-08

Labeling

AMLODIPINE AND OLMESARTAN MEDOXOMIL 2025-02-14

EFAVIRENZ 2024-12-02

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 50%

1 drugs

Infectious Disease 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Infectious Disease, Immunology

Merck big-pharma

Infectious Disease, Immunology

AbbVie big-pharma

Immunology, Infectious Disease

Johnson & Johnson big-pharma

Immunology, Infectious Disease

GSK big-pharma

Infectious Disease, Immunology

MATRIX LABS LTD

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (14)

Active (2)

Discontinued (2)

Company Info